Clinical Trials Directory

Trials / Unknown

UnknownNCT04113486

Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study aims to observe the difference between NMAP (nicotinamide metabolism associated protein) serum levels in primary diagnosed renal cancer patients and non-renal cancer patient controls, plot the ROC curve and establish appropriate cut-off values.

Conditions

Interventions

TypeNameDescription
OTHERBlood testAbout 4 ml of blood draw

Timeline

Start date
2019-10-01
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2019-10-02
Last updated
2020-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04113486. Inclusion in this directory is not an endorsement.